Inhibrx Biosciences, Inc. (CIK: 0002007919) EDGAR, Information, Filings... CompaniesBIO.Com

Inhibrx Biosciences, Inc.

Mailing address
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, Delaware, 92037
Phone
(858) 795-4220
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Inhibrx Biosciences, Inc. (CIK: 0002007919) is an American company incorporated in the state of California. Head office is located at 11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, California, 92037. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Inhibrx Biosciences, Inc. is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Inhibrx Biosciences, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0002007919-24-000024 ( Act) Size: 9 KB	Jun-24-2024
EFFECT	Document	Acc-no: 9999999995-24-001886 (33 Act) Size: 1 KB	Jun-18-2024	333-280127 241053921
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0002007919-24-000022 (33 Act) Size: 13617 KB	Jun-18-2024	333-280127 241053167
8-K	Document	Current report filing Acc-no: 0002007919-24-000016 (34 Act) Size: 3557 KB	Jun-17-2024	001-42031 241048154
S-1	Document	General form of registration statement for all companies including face-amount certificate companies Acc-no: 0002007919-24-000011 (33 Act) Size: 14470 KB	Jun-11-2024	333-280127 241036689
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0002007919-24-000008 ( Act) Size: 7 KB	Jun-07-2024
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000905148-24-001689 (34 Act) Size: 422 KB	Jun-07-2024	005-94527 241029848
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0000905148-24-001688 ( Act) Size: 21 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0002007919-24-000006 ( Act) Size: 13 KB	Jun-04-2024
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950142-24-001549 (34 Act) Size: 60 KB	Jun-03-2024	005-94527 241015748
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950142-24-001548 (34 Act) Size: 39 KB	Jun-03-2024	005-94527 241015747
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001140361-24-028380 (34 Act) Size: 64 KB	May-31-2024	005-94527 241010265
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-067359 ( Act) Size: 5 KB	May-31-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950142-24-001495 ( Act) Size: 5 KB	May-30-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950142-24-001494 ( Act) Size: 5 KB	May-30-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950142-24-001493 ( Act) Size: 11 KB	May-30-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950142-24-001492 ( Act) Size: 12 KB	May-30-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950142-24-001491 ( Act) Size: 8 KB	May-30-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950142-24-001490 ( Act) Size: 12 KB	May-30-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950142-24-001489 ( Act) Size: 5 KB	May-30-2024

Recent 20 filings. View all Inhibrx Biosciences, Inc. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Inhibrx Biosciences, Inc. overview
Inhibrx Biosciences, Inc. job
Inhibrx Biosciences, Inc. stock
Inhibrx Biosciences, Inc. ownership
Inhibrx Biosciences, Inc. CEO
Inhibrx Biosciences, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.